SPOLVERINI, AMBRA
SPOLVERINI, AMBRA
Analysis of polymorphic variants and new mutations in patients with Chronic Myeloporiliferative Neoplasms
2013 Ambra Spolverini
Concomitant occurrence of BCR-ABL and JAK2V617F mutation.
2011 L. Pieri; A. Spolverini;B. Scappini;U. Occhini;S. Birtolo;A. Bosi;F. Albano;C. Fava;A.M. Vannucchi
Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis.
2010 P. Guglielmelli;F. Biamonte;A. Spolverini;L. Pieri;A. Isgrò;E. Antonioli;A. Pancrazzi;A. Bosi;G. Barosi;A.M. Vannucchi
Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative 'idiopathic' erythrocytosis.
2013 Spolverini A;Pieri L;Guglielmelli P;Pancrazzi A;Fanelli T;Paoli C;Bosi A;Nichele I;Ruggeri M;Vannucchi AM
JAK2 46/1 haplotype predisposes tosplanchnic vein thrombosis-associated BCR-ABL negative classic myeloproliferativeneoplasms.
2012 L. Villani;G. Bergamaschi;M. Primignani;V. Rosti;A. Carolei;V. Poletto;P. Catarsi;A. Spolverini;A.M. Vannucchi;G. Barosi.
Mutations and prognosis in primary myelofibrosis.
2013 Vannucchi AM;Lasho TL;Guglielmelli P;Biamonte F;Pardanani A;Pereira A;Finke C;Score J;Gangat N;Mannarelli C;Ketterling RP;Rotunno G;Knudson RA;Susini MC;Laborde RR;Spolverini A;Pancrazzi A;Pieri L;Manfredini R;Tagliafico E;Zini R;Jones A;Zoi K;Reiter A;Duncombe A;Pietra D;Rumi E;Cervantes F;Barosi G;Cazzola M;Cross NC;Tefferi A
The ERCC2 Gln/Gln polymorphism at codon 751 is not associated with leukaemic transformation in primary myelofibrosis.
2013 Susini MC;Guglielmelli P;Spolverini A;Biamonte F;Mannarelli C;Barosi G;Zoi K;Reiter A;Duncombe A;Cervantes F;Cazzola M;Cross N;Vannucchi AM.
The myeloproliferative neoplasm-associated JAK2 46/1 haplotype is not overrepresented in chronic myelogenous leukemia.
2011 Spolverini A; Jones AV; Hochhaus A; Pieri L; Cross NC; Vannucchi AM.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Analysis of polymorphic variants and new mutations in patients with Chronic Myeloporiliferative Neoplasms | 2013 | Ambra Spolverini | |
| Concomitant occurrence of BCR-ABL and JAK2V617F mutation. | 2011 | L. Pieri; A. Spolverini;B. Scappini;U. Occhini;S. Birtolo;A. Bosi;F. Albano;C. Fava;A.M. Vannucchi | |
| Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis. | 2010 | P. Guglielmelli;F. Biamonte;A. Spolverini;L. Pieri;A. Isgrò;E. Antonioli;A. Pancrazzi;A. Bosi;G. Barosi;A.M. Vannucchi | |
| Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative 'idiopathic' erythrocytosis. | 2013 | Spolverini A;Pieri L;Guglielmelli P;Pancrazzi A;Fanelli T;Paoli C;Bosi A;Nichele I;Ruggeri M;Vannucchi AM | |
| JAK2 46/1 haplotype predisposes tosplanchnic vein thrombosis-associated BCR-ABL negative classic myeloproliferativeneoplasms. | 2012 | L. Villani;G. Bergamaschi;M. Primignani;V. Rosti;A. Carolei;V. Poletto;P. Catarsi;A. Spolverini;A.M. Vannucchi;G. Barosi. | |
| Mutations and prognosis in primary myelofibrosis. | 2013 | Vannucchi AM;Lasho TL;Guglielmelli P;Biamonte F;Pardanani A;Pereira A;Finke C;Score J;Gangat N;Mannarelli C;Ketterling RP;Rotunno G;Knudson RA;Susini MC;Laborde RR;Spolverini A;Pancrazzi A;Pieri L;Manfredini R;Tagliafico E;Zini R;Jones A;Zoi K;Reiter A;Duncombe A;Pietra D;Rumi E;Cervantes F;Barosi G;Cazzola M;Cross NC;Tefferi A | |
| The ERCC2 Gln/Gln polymorphism at codon 751 is not associated with leukaemic transformation in primary myelofibrosis. | 2013 | Susini MC;Guglielmelli P;Spolverini A;Biamonte F;Mannarelli C;Barosi G;Zoi K;Reiter A;Duncombe A;Cervantes F;Cazzola M;Cross N;Vannucchi AM. | |
| The myeloproliferative neoplasm-associated JAK2 46/1 haplotype is not overrepresented in chronic myelogenous leukemia. | 2011 | Spolverini A; Jones AV; Hochhaus A; Pieri L; Cross NC; Vannucchi AM. |